Searchable abstracts of presentations at key conferences in endocrinology

ea0032p905 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

The effects of cabergoline treatment on cardiac valves in patients with prolactinoma

Sarac Fulden , Sarac Sefa , Tutuncuoglu Pelin

Introduction: Dopamine agonists have been reported to increase the risk of cardiac valve regurgitation in valve disease risks for 3 years treatment with cabergoline in patients with prolactinma. The aim of the study was to evaluate the frequency of cardiac valve diseases and regurgitation in patients with prolactinoma at the end of 3 years.Subjects and method: Thirty-one patients with prolactinoma who had received cabergoline following 3 years were enrol...

ea0041ep1062 | Thyroid (non-cancer) | ECE2016

A nonspecific complaint such as diarrhea in elderly with hyperthyroidism: evaluation with a case

Sarac Sefa , Tutuncuoglu Pelın , Savas Sumru , Sarac Fulden

Introduction: Hyperthyroidism in the elderly can present with subtle nonspecific complaints. Patients with long-standing goiter can develop autonomous nodules resulting in toxic nodular goiter.Case report: An 86 year old women was referred from gastroenterologist for thyroid disease because of low TSH. She had diarrhea with five to eight bowel movements a day for six months. She denied palpitations, heat intolerance or muscle weakness. She had been noted...

ea0037ep319 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Insulin receptor substrate 1 and 2 genes polymorphisms are associated with metabolic syndrome but not cardiovascular risk factors in patients with metabolic syndrome

Sarac Fulden , Sarac Sefa , Savas Sumru , Akcicek Fehmi

Objective: The aim of our study was to investigate the relationships between insulin receptor substrat-1 (IRS-1) and insulin receptor substrat-2 (IRS-2) gene polymorphisms and cardiovascular factors such as blood pressures, BMI, LDL- cholesterol, triglyceride, HOMA-IR, homocysteine, hsCRP and fibrinogen levels in patients with metabolic syndrome (MetS).Subjects and methods: The study population included 100 patients with MetS and 30 patients without MetS...

ea0037ep321 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

Vitamin B12 levels and relationship between B12 and fasting insulin levels elderly patients with metabolic syndrome

Sarac Fulden , Savas Sumru , Sarac Sefa , Akcicek Fehmi

Introduction: Biochemical and clinical vitamin B12 deficiency has been demonstrated to be highly prevalent among patients with diabetes mellitus. The aims of the study were 1. to compare the vitamin B12 (VB12) levels, and 2. to investigate the relationship between VB12, fasting insulin and HOMA-IR levels in elderly patients with metabolic syndrome (MetS).Subjects and method: Study population included 121 (mean age 64.3±14.1 years) (80 female, 41 mal...

ea0037ep562 | Obesity and cardiovascular endocrinology | ECE2015

Comparison of demographic and biochemical characteristics among younger and older patients with metabolic syndrome

Tutuncuoglu Pelin , Sarac Fulden , Savas Sumru , Sarac Sefa

Aims: The metabolic syndrome (MetS) is a summary measure of important CVD risk factors that frequently coexist. The syndrome is evident in 20–30% of middle-aged women and has been linked to the development of CVD and diabetes. The aim of the study was to examine the differences in demographic and clinical profiles among older (≥60 years) and younger (<60 years) patients with MetS.Methods: The study was included 45 older (mean age 63.1&#177...